Authors:
Sandell, J
Halldin, C
Pike, VW
Chou, YH
Varnas, K
Hall, H
Marchais, S
Nowicki, B
Wikstrom, HV
Swahn, CG
Farde, L
Citation: J. Sandell et al., New halogenated [C-11]WAY analogues, [C-11]6FPWAY and [C-11]6BPWAY - Radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey, NUCL MED BI, 28(2), 2001, pp. 177-185
Authors:
Westerink, BHC
Kawahara, Y
De Boer, P
Geels, C
De Vries, JB
Wikstrom, HV
Van Kalkeren, A
Van Vliet, B
Kruse, CG
Long, SK
Citation: Bhc. Westerink et al., Antipsychotic drugs classified by their effects on the release of dopamineand noradrenaline in the prefrontal cortex and striatum, EUR J PHARM, 412(2), 2001, pp. 127-138
Authors:
Cremers, TIFH
Wiersma, LJ
Bosker, FJ
den Boer, JA
Westerink, BHC
Wikstrom, HV
Citation: Tifh. Cremers et al., Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?, BIOL PSYCHI, 50(1), 2001, pp. 13-21
Citation: U. Jurva et al., In vitro mimicry of metabolic oxidation reactions by electrochemistry/massspectrometry, RAP C MASS, 14(6), 2000, pp. 529-533
Authors:
Mensonides-Harsema, MM
Liao, Y
Bottcher, H
Bartoszyk, GD
Greiner, HE
Harting, J
de Boer, P
Wikstrom, HV
Citation: Mm. Mensonides-harsema et al., Synthesis and in vitro and in vivo functional studies of ortho-substitutedphenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635, J MED CHEM, 43(3), 2000, pp. 432-439
Authors:
Cremers, TIFH
Spoelstra, EN
de Boer, P
Bosker, FJ
Mork, A
den Boer, JA
Westerink, BHC
Wikstrom, HV
Citation: Tifh. Cremers et al., Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram, EUR J PHARM, 397(2-3), 2000, pp. 351-357
Authors:
Cremers, TIFH
de Boer, P
Liao, Y
Bosker, FJ
den Boer, JA
Westerink, BHC
Wikstrom, HV
Citation: Tifh. Cremers et al., Augmentation with a 5-HT1A but not a 5-HT1B receptor antagonist criticallydepends on the dose of citalopram, EUR J PHARM, 397(1), 2000, pp. 63-74
Authors:
Rodenhuis, N
Timmerman, W
Wikstrom, HV
Dijkstra, D
Citation: N. Rodenhuis et al., Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT, EUR J PHARM, 394(2-3), 2000, pp. 255-263
Authors:
Rodenhuis, N
Dijkstra, D
de Boer, P
Vermeulen, ES
Timmerman, W
Wikstrom, HV
Citation: N. Rodenhuis et al., Dopamine D-2 activity of R-(-)-apomorphine and selected analogs: a microdialysis study, EUR J PHARM, 387(1), 2000, pp. 39-45
Citation: Ej. Homan et al., Molecular modeling of the dopamine D-2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT, BIO MED CH, 7(9), 1999, pp. 1805-1820
Authors:
Homan, EJ
Copinga, S
Unelius, L
Jackson, DM
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT, BIO MED CH, 7(7), 1999, pp. 1263-1271
Authors:
Homan, EJ
Kroodsma, E
Copinga, S
Unelius, L
Mohell, N
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., Structural analogues of 5-OMe-BPAT: Synthesis and interactions with dopamine D-2, D-3, and serotonin 5-HT1A receptors, BIO MED CH, 7(6), 1999, pp. 1111-1121
Authors:
Homan, EJ
Tulp, MTM
Nilsson, JE
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., C5-substituted derivatives of 5-OMe-BPAT: Synthesis and interactions with dopamine D-2 and serotonin 5-HT1A receptors, BIO MED CH, 7(11), 1999, pp. 2541-2548
Authors:
Homan, EJ
Copinga, S
Elfstrom, L
van der Veen, T
Hallema, JP
Mohell, N
Unelius, L
Johansson, R
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., 2-aminotetralin-derived substituted benzamides with mixed dopamine D-2, D-3, and serotonin 5-HT1A receptor binding properties: A novel class of potential atypical antipsychotic agents, BIO MED CH, 6(11), 1998, pp. 2111-2126